Geode Capital Management LLC Increases Stock Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE)

Geode Capital Management LLC boosted its position in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) by 0.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 460,768 shares of the company’s stock after acquiring an additional 3,603 shares during the period. Geode Capital Management LLC owned 0.75% of Pulse Biosciences worth $8,024,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. KLP Kapitalforvaltning AS bought a new position in Pulse Biosciences in the 4th quarter valued at $44,000. Caisse Des Depots ET Consignations purchased a new stake in shares of Pulse Biosciences in the fourth quarter worth $95,000. Farther Finance Advisors LLC boosted its stake in Pulse Biosciences by 44.4% during the fourth quarter. Farther Finance Advisors LLC now owns 7,220 shares of the company’s stock valued at $126,000 after buying an additional 2,220 shares during the period. SG Americas Securities LLC purchased a new position in Pulse Biosciences during the fourth quarter worth about $193,000. Finally, Bender Robert & Associates bought a new position in Pulse Biosciences in the 4th quarter worth about $202,000. Hedge funds and other institutional investors own 76.95% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com upgraded Pulse Biosciences to a “sell” rating in a research report on Monday, March 31st.

Pulse Biosciences Price Performance

PLSE stock opened at $19.27 on Friday. The firm has a 50 day simple moving average of $17.11 and a two-hundred day simple moving average of $17.96. Pulse Biosciences, Inc. has a one year low of $6.60 and a one year high of $25.00.

Pulse Biosciences Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.